For unregulated products, this information cannot be independently verified
Immuunsysteem: GLP-1 lijkt ontstekingsremmend te werken en draagt mogelijk bij aan een beter gereguleerde immuunrespons
These drugs also simultaneously decrease levels of an enzyme called DPP-4, which inactivates GLP-1
Background Type 2 diabetes mellitus (T2DM) is a chronic condition that affects millions of patients worldwide, posing significant challenges to both patients and healthcare systems
1 Behind the scenes, though, GLP-1s are raising difficult questions about who has access to the drugs, the long-term health effects and how much the growing demand will drive up health spending
But an excess dose or extra ingredients may mean that you end up with side effects and symptoms beyond those already associated with GLP-1s, including nausea, vomiting, constipation, diarrhea and headaches are all common